- Braveheart Investment Group plc has announced that Pharm2Farm Limited ("Pharm2Farm"), an investee company in which Braveheart has a 33% interest has completed product trials with Griin Agriculture in Korea.

In these trials, Griin used its proprietary vertical hydroponic system, designed to grow the herb basil intensively in indoor, inner city locations.

Over a 20 day harvesting period, the treated plants produced 33 per cent. more leaves with more intense taste than the untreated plants.

Pharm2Farm's coated nanoparticle technology, has been demonstrated to dramatically increase the bioavailability of trace minerals in plant feeds applicable to all areas of the farming market.

At 9:56am: [LON:BRH] Braveheart Investment Group PLC share price was 0p at 11.25p

Story provided by